(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

LASERX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: US

Quick snapshot

LASERX

ST13

US500000077199162

Class

5

Filing

77199162

Registration

3384519

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

31

Latest update

06/22/2017

Classification

Registered

Trademark type

Combined

Nice classes

5

Filing date

06/06/2007

Registration date

02/19/2008

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/22/2017

Last transaction

06/22/2017

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

2005-10-00

First use in commerce

2005-12-00

Drawing code

3

Owner type

16

Owner location

Alpharetta, GA

Examiner

BUTTON, JENNIFER

Law office

M40

Current location

GENERIC WEB UPDATE

Mark description

The mark consists of The word LASER in stylized font with a dot inside the lower portion of the letter "s" and an "Rx" symbol on the letter "r".

Holders and representatives

Holders

LASER PHARMACEUTICALS, LLC
LASER PHARMACEUTICALS, LLC

Representatives

Anuj Desai Arnall Golden Gregory LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceuticalsprescription medications for allergycoughcoldpain management ; pharmaceuticalsprescription medications for woman's healthprenatal vitamins and iron supplements

Publications

History of USPTO decisions and trademark events.

31 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

06/22/2017

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

06/22/2017

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

06/22/2017

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/22/2017

E89R

TEAS SECTION 8 & 9 RECEIVED

05/08/2017

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

02/19/2017

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

10/15/2014

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

03/06/2014

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

03/06/2014

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/06/2014

815F

REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED

02/17/2014

E815

TEAS SECTION 8 & 15 RECEIVED

02/17/2014

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/23/2009

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/03/2009

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/03/2009

R.PR

REGISTERED-PRINCIPAL REGISTER

02/19/2008

PUBO

PUBLISHED FOR OPPOSITION

12/04/2007

NPUB

NOTICE OF PUBLICATION

11/14/2007

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

10/29/2007

ALIE

ASSIGNED TO LIE

10/29/2007

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/27/2007

XAEC

EXAMINER'S AMENDMENT ENTERED

09/27/2007

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

09/27/2007

GNEA

EXAMINERS AMENDMENT E-MAILED

09/27/2007

CNEA

EXAMINERS AMENDMENT -WRITTEN

09/27/2007

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/14/2007

GNRT

NON-FINAL ACTION E-MAILED

09/14/2007

CNRT

NON-FINAL ACTION WRITTEN

09/14/2007

DOCK

ASSIGNED TO EXAMINER

09/13/2007

MDSC

NOTICE OF DESIGN SEARCH CODE MAILED

06/12/2007

NWAP

NEW APPLICATION ENTERED

06/11/2007

Continuous trademark protection

Get notified about every new filing that threatens LASERX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.